Table 1.

Summary of data/biological sample collection

Evaluation	Time points
	Inclusion (D0)	End CT (M3)	M6	M12	Y2	Y3	Y4	Y5	Y6	Y7	Y8	Y9	Y10
Clinical Examination
Pain	X	X	X	X	X	X
Tumour Evaluation		X	X	X	X	X	X	X	X	X	X	X	X
Cardiovascular toxicities				X	X	X	X	X	X	X	X	X	X
Second primary tumour				X	X	X	X	X	X	X	X	X	X
Questionnaires
CRF (QLQ-FA12)	X	X	X	X	X	X	X	X	X	X	X	X	X
HRQoL (QLQ-C30/TC26)	X	X	X	X	X	X	X	X	X	X	X	X	X
Cognition (FACT-Cog)	X	X		X	X	X
Anxiety/depression (HADS)	X	X	X	X	X	X
PA/sedentary levels (ONAPS-PAQ)	X	X	X	X	X	X	X	X	X	X	X	X	X
Pain and neuropathies (VAS)	X	X	X	X	X	X
Nutrition (WCRF)	X	X	X	X	X	X
Sustainable return to work				X	X	X
Motivation (EMAPS)	X	X		X
Satisfaction with the connected activity tracker				X
Satisfaction with the intervention				X
Practice locations	X
Physical condition/fitness
6-min walk test	X	X	X	X	X	X
Sit-to-stand test	X	X	X	X	X	X
Handgrip test	X	X	X	X	X	X
Anthropometrics	X	X	X	X	X	X
Number of steps per day (connected activity tracker)	Every day, non-stop (up to M12)
Heart rate (connected activity tracker)	Non-stop (up to M12)
Sleep quality (connected activity tracker)	Non-stop (up to M12)
Gut microbiota study
Blood sampling	X	X		X		X
Optional faecal sampling	X	X		X		X
Blood biomarkers
Gut microbial metabolites	X	X		X		X
Inflammation/Immunity	X	X		X		X
Liver function	X	X		X		X